Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Apr 9, 2009

Premium

AnaSpec this week introduced new cell-penetrating peptides.

Also called protein transduction domains, the peptides are carriers with small peptide domains that can "freely cross cell membranes," the company said in a statement. Such functionality is needed to deliver the functional domain of a selected protein from the outside to the inside of intact cells.

The new CCPs launched by AnaSpec include antennapedia and TAT.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.